Log in to save to my catalogue

High endogenous CCL2 expression promotes the aggressive phenotype of human inflammatory breast cance...

High endogenous CCL2 expression promotes the aggressive phenotype of human inflammatory breast cance...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_178a7e049b6748368cce8de609f3ab95

High endogenous CCL2 expression promotes the aggressive phenotype of human inflammatory breast cancer

About this item

Full title

High endogenous CCL2 expression promotes the aggressive phenotype of human inflammatory breast cancer

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2021-11, Vol.12 (1), p.6889-6889, Article 6889

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Inflammatory Breast Cancer (IBC) is a highly aggressive malignancy with distinct clinical and histopathological features whose molecular basis is unresolved. Here we describe a human IBC cell line, A3250, that recapitulates key IBC features in a mouse xenograft model, including skin erythema, diffuse tumor growth, dermal lymphatic invasion, and ext...

Alternative Titles

Full title

High endogenous CCL2 expression promotes the aggressive phenotype of human inflammatory breast cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_178a7e049b6748368cce8de609f3ab95

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_178a7e049b6748368cce8de609f3ab95

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-021-27108-8

How to access this item